PMV Pharmaceuticals, Inc.
PMVP
$1.57
$0.010.64%
NASDAQ
| 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | 112.94M | 129.25M | 142.27M | 160.39M | 169.45M |
| Total Receivables | -- | -- | -- | -- | -- |
| Inventory | -- | -- | -- | -- | -- |
| Prepaid Expenses | 2.28M | 3.20M | 3.04M | 3.11M | 6.20M |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | -- | -- | -- | -- | -- |
| Total Current Assets | 115.23M | 132.45M | 145.31M | 163.50M | 175.66M |
|
|
|||||
| Total Current Assets | 115.23M | 132.45M | 145.31M | 163.50M | 175.66M |
| Net Property, Plant & Equipment | 1.04M | 1.15M | 1.26M | 1.44M | 1.55M |
| Long-term Investments | -- | -- | -- | -- | -- |
| Goodwill | -- | -- | -- | -- | -- |
| Total Other Intangibles | -- | -- | -- | -- | -- |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | 297.00K | 249.00K | 248.00K | 237.00K | 235.00K |
| Total Assets | 116.56M | 133.84M | 152.86M | 170.61M | 191.29M |
|
|
|||||
| Total Accounts Payable | 3.16M | 3.40M | 2.60M | 3.59M | 6.58M |
| Total Accrued Expenses | 7.86M | 8.52M | 8.63M | 5.80M | 7.44M |
| Short-term Debt | -- | -- | -- | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | 403.00K | 390.00K | 377.00K | 364.00K | 352.00K |
| Total Finance Division Other Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Current Liabilities | -- | -- | -- | -- | -- |
| Total Current Liabilities | 11.42M | 12.30M | 11.61M | 9.76M | 14.37M |
|
|
|||||
| Total Current Liabilities | 11.42M | 12.30M | 11.61M | 9.76M | 14.37M |
| Long-Term Debt | -- | -- | -- | -- | -- |
| Short-term Debt | -- | -- | -- | -- | -- |
| Capital Leases | 435.00K | 541.00K | 643.00K | 742.00K | 838.00K |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | -- | -- | -- | -- | -- |
| Total Liabilities | 11.85M | 12.85M | 12.25M | 10.50M | 15.21M |
|
|
|||||
| Common Stock & APIC | 551.08M | 549.33M | 547.94M | 546.17M | 544.65M |
| Retained Earnings | -446.45M | -428.42M | -407.36M | -386.15M | -368.71M |
| Treasury Stock & Other | 84.00K | 91.00K | 21.00K | 84.00K | 139.00K |
| Total Common Equity | 104.71M | 121.00M | 140.61M | 160.11M | 176.08M |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | 104.71M | 121.00M | 140.61M | 160.11M | 176.08M |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | 104.71M | 121.00M | 140.61M | 160.11M | 176.08M |
|
|
|||||